Jul 29 |
Should We Be Delighted With Amgen Inc.'s (NASDAQ:AMGN) ROE Of 75%?
|
Jul 29 |
NewAmsterdam heart drug hits trial goal, but data appear to disappoint investors
|
Jul 26 |
Amgen (AMGN) Advances But Underperforms Market: Key Facts
|
Jul 25 |
Amgen (AMGN) Stock Moves -0.39%: What You Should Know
|
Jul 25 |
Amgen Surges As Weight-Loss Trials Drive Excitement
|
Jul 24 |
3 Fabulous Growth Stocks to Buy and Hold Forever
|
Jul 24 |
What Lies in Store for Healthcare ETFs in Q2 Earnings?
|
Jul 23 |
7 Biotech Stocks to Keep on Your Clinical Radar
|
Jul 23 |
3 Stocks That Are Melting Up. Is There Room to Run?
|
Jul 23 |
Amgen, Garmin among relative market leaders poised to outperform in coming months: BTIG
|